These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 25961452)

  • 1. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.
    Burkett PR; Meyer zu Horste G; Kuchroo VK
    J Clin Invest; 2015 Jun; 125(6):2211-9. PubMed ID: 25961452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
    Astry B; Venkatesha SH; Moudgil KD
    Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of Th17 cells in autoimmune diseases.
    Yasuda K; Takeuchi Y; Hirota K
    Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected targets and triggers of autoimmunity.
    Lee Y; Collins M; Kuchroo VK
    J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S56-60. PubMed ID: 24789684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
    Kastirr I; Maglie S; Paroni M; Alfen JS; Nizzoli G; Sugliano E; Crosti MC; Moro M; Steckel B; Steinfelder S; Stölzel K; Romagnani C; Botti F; Caprioli F; Pagani M; Abrignani S; Geginat J
    J Immunol; 2014 Oct; 193(7):3322-31. PubMed ID: 25172491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting IL-17 in autoimmunity and inflammation.
    Kim BS; Park YJ; Chung Y
    Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23: one cytokine in control of autoimmunity.
    Croxford AL; Mair F; Becher B
    Eur J Immunol; 2012 Sep; 42(9):2263-73. PubMed ID: 22949325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Th17 cell differentiation by intestinal commensal bacteria.
    Atarashi K; Tanoue T; Umesaki Y; Honda K
    Benef Microbes; 2010 Nov; 1(4):327-34. PubMed ID: 21831771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
    Du R; Zhao H; Yan F; Li H
    J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-23/IL-17 immune axis in Guillain Barré Syndrome: Exploring newer vistas for understanding pathobiology and therapeutic implications.
    Debnath M; Nagappa M; Murari G; Taly AB
    Cytokine; 2018 Mar; 103():77-82. PubMed ID: 29331587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date.
    Hemdan NY; Birkenmeier G; Wichmann G
    Immunol Lett; 2012 Dec; 148(2):97-109. PubMed ID: 23036716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation.
    Wang J; Li F; Wei H; Lian ZX; Sun R; Tian Z
    J Exp Med; 2014 Nov; 211(12):2397-410. PubMed ID: 25366965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases.
    Schmidt T; Luebbe J; Paust HJ; Panzer U
    Mol Immunol; 2018 Dec; 104():90-99. PubMed ID: 30448610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.